4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-24-018282
CEO, CFO, Director gave up 128 shares (to pay taxes)
- CEO, CFO, Director acquired 443 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2024-05-06 | Option exercise | +232 | 6,688 | D | ||
| Finley John David CEO, CFO, Director | 2024-05-06 | Shares withheld for taxes | −67 | $8.46 | $567 | 6,621 | D |
| Finley John David CEO, CFO, Director | 2024-05-06 | Option exercise | +211 | 6,832 | D | ||
| Finley John David CEO, CFO, Director | 2024-05-06 | Shares withheld for taxes | −61 | $8.46 | $516 | 6,771 | D |
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2024-05-06 | Option exercise · Restricted Stock Units | −232 | 1,622 | D | ||
| Finley John David CEO, CFO, Director | 2024-05-06 | Option exercise · Restricted Stock Units | −211 | 2,111 | D | ||
Loading xslF345X05/ownership.xml…